Genes
Oligo Pools
NGS
Variant Libraries
Synthetic Controls
Antibody Discovery
IVDR Solutions
Webinar
Twist Bioscience HQ
681 Gateway Blvd
South San Francisco, CA 94080
Antibody Discovery and Development Efforts Fueling the Future of Diagnostic Testing
Learn how Twist Biopharma has used its proprietary platform to produce and discover highly specific antibodies which may be used for developing diagnostic tests
In this jointly hosted webinar, you will:
- Hear how Twist Biopharma, a division of Twist Bioscience, has developed a proprietary platform that uses Twist’s high-throughput DNA synthesis to produce and discover highly specific antibodies.
- Learn how this platform has been used to discover over 100 high-affinity antibodies to the SARS-CoV-2 spike protein.
- See how Twist is using the Carterra LSA high throughput surface plasmon resonance (SPR) platform to bypass ELISA screening and proceed directly to binding kinetics and epitope binning after panning, thereby consolidating mAb workflows and reducing time to results.
- Learn how to survey the epitope landscape of your antibody library at the earliest stages of discovery.
Share your details to Watch the Webinar
